Trial Profile
Curcumin against chronic heart failure using a novel drug-delivery system.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jan 2013
Price :
$35
*
At a glance
- Drugs Curcumin (Primary)
- Indications Left ventricular hypertrophy
- Focus Therapeutic Use
- 10 Nov 2011 Status changed from recruiting to completed, according to a Theravalues Corporation media release.
- 10 Nov 2011 Results were reported in a Theravalues Corporation media release.
- 07 Jan 2011 New trial record